From recent updates to patent term extensions and the patent linkage system to fundamental reforms to judicial enforcement and regulatory exclusivities, the Chinese life science legal landscape has undergone change on a seismic scale in recent years.
This compare-and-contrast session will examine how China’s evolving patent linkage system, PTE regime, regulatory exclusivities and enforcement landscape compare with similar frameworks in Europe, and what this means for your international strategy.
- Patent Term Extensions - How well is the system working? What are the core issues? How does it compare to SPC protection?
- Patent Linkage System – How well is it working? Where are the difficulties for companies? Does it provide a different level of certainty around the time of exclusivity loss and generic entry compared to the EU?
- Data Exclusivity & RDP – How are protections changing in China? Are the new regulatory frameworks converging with those in the EU?
- How similar is the patent litigation and antitrust enforcement landscape between China and the EU?
